News from the healthcare data industry
SOLANA BEACH, Calif. and CHICAGO, Feb. 02, 2022 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company primarily focused on treatments for gastrointestinal (GI) diseases, and EVERSANA...
HAYWARD, Calif., Feb. 1, 2022 /PRNewswire/ — AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced...
January 27, 2022 08:00 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Cognito Therapeutics and Providence Health Plan today announced a collaboration to conduct a Phase 3 study of Cognito’s breakthrough, non-invasive...
The dermatology community remains concerned about the risk of COVID-19 in individuals with atopic dermatitis (AD). Using Symphony Health-derived data from the COVID-19 Research Database,1Â we aimed to assess the risk...
Syapse will continue to identify, validate, and address discrepancies in real-world data, producing an accurate and fully contextualized narrative of a patient’s experience January 20, 2022 10:00 ET | Source: Syapse …...
REDMOND, Wash. and ATLANTA, Jan. 18, 2022 (GLOBE NEWSWIRE) — Truveta, the health system-led company with a vision of saving lives with data, and the Health Care business of LexisNexis...
Immune checkpoint inhibitors, which strengthen the immune response against tumor cells, have become standard of care for many patients with advanced cancers; however, the medications can often cause side effects,...
Data demonstrates that intravenous ketamine is a rapid and robust treatment for depression. These results can inform clinical best practices and provide real-world evidence to advocate for better insurance coverage.January...
Collaboration will focus on co-development of unique datasets to understand health in everyday lifeJanuary 10, 2022 06:00 AM Eastern Standard Time SAN MATEO, Calif.–(BUSINESS WIRE)–Evidation, the company creating new ways...
SAN FRANCISCO, Jan. 04, 2022 (GLOBE NEWSWIRE) — Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today announced a...